title: Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.
abstract: Adaptive responding to threatening stressors is of fundamental importance for survival. Dysfunctional hyperactivation of corticotropin releasing factor type-1 (CRF(1)) receptors in stress response system pathways is linked to stress-related psychopathology and CRF(1) receptor antagonists (CRAs) have been proposed as novel therapeutic agents. CRA effects in diverse animal models of stress that detect anxiolytics and/or antidepressants are reviewed, with the goal of evaluating their potential therapeutic utility in depression, anxiety, and other stress-related disorders. CRAs have a distinct phenotype in animals that has similarities to, and differences from, those of classic antidepressants and anxiolytics. CRAs are generally behaviorally silent, indicating that CRF(1) receptors are normally in a state of low basal activation. CRAs reduce stressor-induced HPA axis activation by blocking pituitary and possibly brain CRF(1) receptors which may ameliorate chronic stress-induced pathology. In animal models sensitive to anxiolytics and/or antidepressants, CRAs are generally more active in those with high stress levels, conditions which may maximize CRF(1) receptor hyperactivation. Clinically, CRAs have demonstrated good tolerability and safety, but have thus far lacked compelling efficacy in major depressive disorder, generalized anxiety disorder, or irritable bowel syndrome. CRAs may be best suited for disorders in which stressors clearly contribute to the underlying pathology (e.g. posttraumatic stress disorder, early life trauma, withdrawal/abstinence from addictive substances), though much work is needed to explore these possibilities. An evolving literature exploring the genetic, developmental and environmental factors linking CRF(1) receptor dysfunction to stress-related psychopathology is discussed in the context of improving the translational value of current animal models.
authors.affiliation: Translational Neuropharmacology Consulting, LLC, 9710 Traville Gateway Drive #307, Rockville, MD 20850-7408, USA. jkehne@gmail.com
authors.forename: John H
authors.initials: JH
authors.lastname: Kehne
authors.forename: Christopher K
authors.initials: CK
authors.lastname: Cain
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy* / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D051381:Rats; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013315:Stress, Psychological / Q000188:drug therapy* / Q000378:metabolism; D000099052:CRF Receptor, Type 1
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D018019:Receptors, Corticotropin-Releasing Hormone; D000099052:CRF Receptor, Type 1
references.citation: Eur J Neurosci. 2007 Jun;25(11):3385-97
references.pmid: 17553007
references.citation: Gend Med. 2005 Sep;2(3):146-54
references.pmid: 16290887
references.citation: J Clin Psychiatry. 2004;65 Suppl 1:18-28
references.pmid: 14728093
references.citation: CNS Spectr. 2005 Feb;10(2):99-106
references.pmid: 15685120
references.citation: Stress. 2009 Mar;12(2):125-33
references.pmid: 18609302
references.citation: NeuroRx. 2006 Jan;3(1):82-96
references.pmid: 16490415
references.citation: Br J Pharmacol. 2004 Apr;141(8):1321-30
references.pmid: 15100165
references.citation: Eur J Pharmacol. 2004 Sep 19;499(1-2):135-46
references.pmid: 15363960
references.citation: CNS Drug Rev. 2003 Spring;9(1):57-96
references.pmid: 12595912
references.citation: J Pharmacol Exp Ther. 2004 Apr;309(1):293-302
references.pmid: 14742750
references.citation: Biol Psychiatry. 2006 Apr 1;59(7):594-602
references.pmid: 16197926
references.citation: Neuropsychopharmacology. 2002 Aug;27(2):194-202
references.pmid: 12093593
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1196-204
references.pmid: 18384079
references.citation: J Clin Endocrinol Metab. 2000 Nov;85(11):4138-45
references.pmid: 11095445
references.citation: Horm Behav. 2003 Nov;44(4):338-45
references.pmid: 14613728
references.citation: J Comp Physiol Psychol. 1969 Mar;67(3):370-5
references.pmid: 5787388
references.citation: Eur J Neurosci. 2001 Jan;13(2):373-80
references.pmid: 11168542
references.citation: Exp Gerontol. 1999 Sep;34(6):721-32
references.pmid: 10579633
references.citation: Psychopharmacology (Berl). 1991;105(4):513-20
references.pmid: 1771219
references.citation: J Trauma Stress. 1997 Jan;10(1):37-49
references.pmid: 9018676
references.citation: Neuropsychopharmacology. 2009 May;34(6):1494-503
references.pmid: 19020499
references.citation: Behav Cogn Neurosci Rev. 2004 Mar;3(1):23-41
references.pmid: 15191640
references.citation: Behav Neurosci. 1999 Oct;113(5):902-13
references.pmid: 10571474
references.citation: Depress Anxiety. 2010 May;27(5):417-25
references.pmid: 20455246
references.citation: Biol Psychiatry. 2004 Jul 15;56(2):113-20
references.pmid: 15231443
references.citation: Eur J Pharmacol. 2004 Aug 16;497(1):49-53
references.pmid: 15321734
references.citation: Biol Psychiatry. 1996 Apr 15;39(8):703-7
references.pmid: 8731457
references.citation: Behav Brain Res. 2008 Mar 17;188(1):154-67
references.pmid: 18067977
references.citation: Pharmacol Biochem Behav. 2004 Feb;77(2):405-13
references.pmid: 14751471
references.citation: J Neurosci. 2009 Jun 3;29(22):7379-88
references.pmid: 19494159
references.citation: Eur J Pharmacol. 2004 May 25;492(2-3):195-201
references.pmid: 15178365
references.citation: Behav Brain Res. 2010 Mar 17;208(1):72-9
references.pmid: 19896506
references.citation: Pavlov J Biol Sci. 1980 Oct-Dec;15(4):177-82
references.pmid: 7208128
references.citation: Mol Psychiatry. 2010 Jun;15(6):574-88
references.pmid: 20010888
references.citation: Neuroscience. 2003;117(1):129-38
references.pmid: 12605899
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8283-8
references.pmid: 10393986
references.citation: Mol Psychiatry. 2006 Jun;11(6):594-602
references.pmid: 16550213
references.citation: Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S207-14
references.pmid: 14677081
references.citation: Psychopharmacology (Berl). 2010 Jan;208(1):109-19
references.pmid: 19911168
references.citation: Learn Mem. 1994 May-Jun;1(1):34-44
references.pmid: 10467584
references.citation: J Psychiatr Res. 2006 Feb;40(1):1-21
references.pmid: 16242154
references.citation: Eur J Pharmacol. 2002 Dec 20;457(2-3):201-6
references.pmid: 12464367
references.citation: Biol Psychiatry. 2005 Jun 15;57(12):1485-92
references.pmid: 15953484
references.citation: Biol Psychiatry. 2008 Jan 15;63(2):137-8
references.pmid: 18164903
references.citation: Crit Rev Neurobiol. 1996;10(3-4):419-46
references.pmid: 8978989
references.citation: Eur J Pharmacol. 2008 Apr 7;583(2-3):174-85
references.pmid: 18282566
references.citation: Psychopharmacology (Berl). 2008 Sep;199(4):569-82
references.pmid: 18516596
references.citation: CNS Neurol Disord Drug Targets. 2006 Apr;5(2):147-65
references.pmid: 16611089
references.citation: Peptides. 2004 Apr;25(4):659-66
references.pmid: 15165722
references.citation: J Neurosci. 2004 Feb 11;24(6):1478-85
references.pmid: 14960621
references.citation: J Clin Psychiatry. 2001;62 Suppl 8:38-45; discussion 46-7
references.pmid: 12108820
references.citation: J Pharmacol Exp Ther. 2000 Jun;293(3):799-806
references.pmid: 10869378
references.citation: CNS Neurol Disord Drug Targets. 2006 Oct;5(5):503-12
references.pmid: 17073653
references.citation: Pharmacol Biochem Behav. 1989 Apr;32(4):919-26
references.pmid: 2798541
references.citation: Ann N Y Acad Sci. 1997 Jun 21;821:305-31
references.pmid: 9238214
references.citation: J Trauma Stress. 2007 Aug;20(4):435-47
references.pmid: 17721957
references.citation: Peptides. 2001 May;22(5):845-51
references.pmid: 11337099
references.citation: Biol Psychiatry. 2006 Aug 15;60(4):329-36
references.pmid: 16412988
references.citation: Eur J Pharmacol. 2003 Feb 28;463(1-3):199-216
references.pmid: 12600711
references.citation: Science. 1984 Dec 14;226(4680):1342-4
references.pmid: 6334362
references.citation: Ann N Y Acad Sci. 1998 Jun 30;851:371-87
references.pmid: 9668628
references.citation: Behav Brain Res. 2003 Jan 22;138(2):207-13
references.pmid: 12527451
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3428-33
references.pmid: 16492789
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10477-82
references.pmid: 8816826
references.citation: Nebr Symp Motiv. 1996;43:251-328
references.pmid: 8912311
references.citation: Pain. 2005 Jun;115(3):398-409
references.pmid: 15911167
references.citation: Philos Trans R Soc Lond B Biol Sci. 1997 Nov 29;352(1362):1675-87
references.pmid: 9415919
references.citation: J Clin Psychiatry. 2003;64 Suppl 1:19-23
references.pmid: 12625801
references.citation: Neuroscience. 2007 Jun 8;146(4):1495-503
references.pmid: 17478046
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15236-41
references.pmid: 17015825
references.citation: J Pharmacol Exp Ther. 2004 Sep;310(3):1027-34
references.pmid: 15115804
references.citation: Endocrinol Metab Clin North Am. 2002 Mar;31(1):37-62, vi
references.pmid: 12055990
references.citation: Peptides. 2010 Apr;31(4):662-70
references.pmid: 20096320
references.citation: Neuropsychopharmacology. 2005 Jan;30(1):90-8
references.pmid: 15138444
references.citation: Neuropsychopharmacology. 2007 Sep;32(9):1941-9
references.pmid: 17287823
references.citation: Biol Psychiatry. 2003 Dec 15;54(12):1376-81
references.pmid: 14675801
references.citation: Metabolism. 2005 May;54(5 Suppl 1):20-3
references.pmid: 15877308
references.citation: Gut. 2004 Jul;53(7):958-64
references.pmid: 15194643
references.citation: J Affect Disord. 2000 Dec;61(3):137-59
references.pmid: 11163418
references.citation: Psychopharmacology (Berl). 2002 Dec;165(1):86-92
references.pmid: 12474122
references.citation: Behav Brain Res. 1999 Apr;100(1-2):207-15
references.pmid: 10212068
references.citation: Behav Neurosci. 2004 Apr;118(2):443-8
references.pmid: 15113272
references.citation: J Neurosci. 2007 Mar 7;27(10):2718-26
references.pmid: 17344409
references.citation: Psychopharmacology (Berl). 2011 Mar;214(1):221-9
references.pmid: 20499051
references.citation: Eur J Pharmacol. 2005 Feb 21;509(2-3):145-53
references.pmid: 15733549
references.citation: N Y State J Med. 1975 Oct;75(12):2139-45
references.pmid: 1059917
references.citation: Neurosci Biobehav Rev. 2001 Dec;25(7-8):627-36
references.pmid: 11801288
references.citation: Annu Rev Psychol. 2005;56:235-62
references.pmid: 15709935
references.citation: J Pharmacol Exp Ther. 2002 Apr;301(1):322-32
references.pmid: 11907190
references.citation: Front Behav Neurosci. 2009 Sep 01;3:22
references.pmid: 19750195
references.citation: Neuroscience. 2006;138(1):235-43
references.pmid: 16359808
references.citation: Physiol Behav. 2004 Sep 30;82(4):751-62
references.pmid: 15327926
references.citation: Hippocampus. 2006;16(2):114-24
references.pmid: 16281294
references.citation: J Comp Physiol Psychol. 1975 Jan;88(1):81-8
references.pmid: 1120819
references.citation: J Neurosci. 2003 Dec 10;23(36):11436-43
references.pmid: 14673008
references.citation: Eur J Pharmacol. 1999 Apr 29;371(2-3):205-11
references.pmid: 10357258
references.citation: CNS Spectr. 2005 Nov;10(11):899-908
references.pmid: 16273019
references.citation: J Neurosci. 2009 Dec 16;29(50):15745-55
references.pmid: 20016090
references.citation: Psychopharmacology (Berl). 2002 Jan;159(3):304-10
references.pmid: 11862363
references.citation: J Pharmacol Exp Ther. 2002 Jul;302(1):145-52
references.pmid: 12065711
references.citation: J Exp Psychol Anim Behav Process. 2003 Oct;29(4):323-33
references.pmid: 14570519
references.citation: Behav Brain Res. 2007 Nov 2;183(2):178-87
references.pmid: 17645963
references.citation: Curr Drug Targets CNS Neurol Disord. 2002 Oct;1(5):467-93
references.pmid: 12769601
references.citation: Science. 2000 Jan 14;287(5451):248-51
references.pmid: 10634773
references.citation: Eur J Pharmacol. 2000 Jul 28;401(1):39-46
references.pmid: 10915835
references.citation: Pharmacol Biochem Behav. 2004 Mar;77(3):447-55
references.pmid: 15006454
references.citation: Pharmacol Biochem Behav. 2005 Dec;82(4):652-7
references.pmid: 16359723
references.citation: Eur J Pharmacol. 1990 Nov 6;190(1-2):11-21
references.pmid: 1963846
references.citation: Mol Pain. 2007 Jun 05;3:13
references.pmid: 17550594
references.citation: J Clin Psychiatry. 1989 May;50 Suppl:13-20; discussion 21-2
references.pmid: 2654128
references.citation: Pharmacol Biochem Behav. 2002 Mar;71(3):379-92
references.pmid: 11830172
references.citation: Nature. 2000 Aug 17;406(6797):722-6
references.pmid: 10963596
references.citation: J Trauma Stress. 2006 Oct;19(5):571-81
references.pmid: 17075906
references.citation: Expert Opin Ther Targets. 2005 Aug;9(4):651-84
references.pmid: 16083336
references.citation: Int J Neuropsychopharmacol. 2010 Jul;13(6):747-57
references.pmid: 19751543
references.citation: Mol Psychiatry. 2004 Mar;9(3):278-86, 224
references.pmid: 14699428
references.citation: Arch Gen Psychiatry. 2008 Feb;65(2):190-200
references.pmid: 18250257
references.citation: Behav Neurosci. 2008 Apr;122(2):282-92
references.pmid: 18410168
references.citation: Pharmacol Biochem Behav. 1988 Aug;30(4):801-7
references.pmid: 3265790
references.citation: J Pharmacol Exp Ther. 2007 Dec;323(3):846-54
references.pmid: 17855476
references.citation: Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S13-6
references.pmid: 12404664
references.citation: Am J Psychiatry. 2004 Feb;161(2):195-216
references.pmid: 14754765
references.citation: Eur J Pharmacol. 1991 Feb 14;193(3):283-92
references.pmid: 1675993
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: Acta Psychiatr Scand Suppl. 2003;(417):38-50
references.pmid: 12950435
references.citation: J Psychopharmacol. 2003 Sep;17(3):252-9
references.pmid: 14513913
references.citation: J Pharmacol Exp Ther. 2003 Apr;305(1):86-96
references.pmid: 12649356
references.citation: Pharmacol Biochem Behav. 2004 Apr;77(4):855-65
references.pmid: 15099932
references.citation: Brain Res. 2002 Oct 18;952(2):188-99
references.pmid: 12376179
references.citation: Annu Rev Psychol. 2005;56:207-34
references.pmid: 15709934
references.citation: Eur J Pharmacol. 1995 Sep 15;284(1-2):109-18
references.pmid: 8549613
references.citation: Neuroscience. 2001;102(2):329-39
references.pmid: 11166119
references.citation: Learn Mem. 2006 Sep-Oct;13(5):506-14
references.pmid: 17015847
references.citation: Pharmacol Biochem Behav. 2008 Jul;90(1):51-7
references.pmid: 18485466
references.citation: Neuropsychopharmacology. 2004 Jun;29(6):1112-21
references.pmid: 14997174
references.citation: J Neurosci. 2002 Apr 1;22(7):2926-35
references.pmid: 11923457
references.citation: Arch Gen Psychiatry. 1992 Jan;49(1):9-20
references.pmid: 1370198
references.citation: Mol Psychiatry. 2003 Mar;8(3):324-32
references.pmid: 12660805
references.citation: Pharmacol Biochem Behav. 2008 Feb;88(4):497-510
references.pmid: 18031798
references.citation: Biol Psychiatry. 2008 Aug 15;64(4):293-301
references.pmid: 18406399
references.citation: Learn Mem. 2008 Jan 29;15(2):84-7
references.pmid: 18235108
references.citation: J Pharmacol Exp Ther. 2000 Aug;294(2):588-97
references.pmid: 10900236
references.citation: Brain Res. 2008 Oct 9;1234:59-65
references.pmid: 18703034
references.citation: Neuroscience. 2007 Dec 19;150(4):818-28
references.pmid: 17988803
references.citation: CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79
references.pmid: 16918397
references.citation: J Clin Psychiatry. 1999;60 Suppl 6:20-4
references.pmid: 10235121
references.citation: Proc Assoc Am Physicians. 1999 Jan-Feb;111(1):22-34
references.pmid: 9893154
references.citation: Gut. 2004 Jul;53(7):919-21
references.pmid: 15194633
references.citation: J Pharmacol Exp Ther. 1999 May;289(2):926-35
references.pmid: 10215672
references.citation: Psychopharmacology (Berl). 2003 Apr;166(4):408-15
references.pmid: 12590355
references.citation: CNS Neurol Disord Drug Targets. 2007 Jun;6(3):163-82
references.pmid: 17511614
references.citation: Psychopharmacology (Berl). 2003 Nov;170(2):178-87
references.pmid: 12845406
references.citation: Hippocampus. 2001;11(2):90-1
references.pmid: 11345129
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8809-10
references.pmid: 18583480
references.citation: Neuropsychopharmacology. 1990 Feb;3(1):51-9
references.pmid: 2137699
references.citation: Endocr Rev. 2006 May;27(3):260-86
references.pmid: 16484629
references.citation: Pharmacol Rev. 2001 Jun;53(2):209-43
references.pmid: 11356984
references.citation: Brain Res. 2004 Aug 13;1017(1-2):234-7
references.pmid: 15261120
references.citation: J Neurophysiol. 2007 Jun;97(6):3893-904
references.pmid: 17392412
references.citation: Depress Anxiety. 2005;21(1):18-25
references.pmid: 15782425
references.citation: J Med Chem. 1996 Oct 25;39(22):4358-60
references.pmid: 8893829
references.citation: Neuropsychopharmacology. 2002 May;26(5):574-82
references.pmid: 11927182
references.citation: Eur J Pharmacol. 2008 Apr 7;583(2-3):215-25
references.pmid: 18342852
references.citation: Neuropsychopharmacology. 1992 Feb;6(2):69-75
references.pmid: 1610487
references.citation: Behav Brain Res. 2000 Dec 20;117(1-2):163-71
references.pmid: 11099770
references.citation: Neuropsychopharmacology. 2009 May;34(6):1533-42
references.pmid: 19078950
references.citation: Behav Brain Res. 1993 Dec 20;58(1-2):155-65
references.pmid: 7907880
references.citation: Neuropsychopharmacology. 2001 Oct;25(4):585-600
references.pmid: 11557172
references.citation: Am J Psychiatry. 2001 Oct;158(10):1612-6
references.pmid: 11578992
references.citation: Alcohol. 2004 Feb;32(2):101-11
references.pmid: 15163561
references.citation: Int J Neuropsychopharmacol. 2010 May;13(4):515-25
references.pmid: 19653930
references.citation: J Pharmacol Exp Ther. 2003 Feb;304(2):874-80
references.pmid: 12538845
references.citation: Neuropsychopharmacology. 2004 Apr;29(4):641-8
references.pmid: 15034558
references.citation: J Neurochem. 2003 Mar;84(6):1378-86
references.pmid: 12614338
references.citation: Biol Psychiatry. 2001 Oct 1;50(7):510-20
references.pmid: 11600104
references.citation: J Psychopharmacol. 2007 Jan;21(1):42-9
references.pmid: 16533865
references.citation: Neuropharmacology. 2000 Jun 8;39(8):1357-67
references.pmid: 10818252
references.citation: Neurochem Res. 2003 Nov;28(11):1735-42
references.pmid: 14584827
references.citation: Ann N Y Acad Sci. 1999 Oct 20;885:312-28
references.pmid: 10816663
references.citation: Life Sci. 2001 Aug 3;69(11):1241-8
references.pmid: 11521748
references.citation: Science. 2003 Jun 20;300(5627):1952-3
references.pmid: 12817151
references.citation: J Neurosci. 1999 Jun 15;19(12):5016-25
references.pmid: 10366634
references.citation: Neuropsychopharmacology. 2006 Oct;31(10):2180-7
references.pmid: 16452986
references.citation: CNS Drug Rev. 2005 Spring;11(1):21-52
references.pmid: 15867951
references.citation: Mol Psychiatry. 2002;7(3):254-75
references.pmid: 11920153
references.citation: Neuropsychopharmacology. 2003 Jul;28(7):1328-35
references.pmid: 12784115
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):625-31
references.pmid: 12787849
references.citation: Psychopharmacology (Berl). 2004 Oct;176(1):30-8
references.pmid: 15071721
references.citation: Pharmacol Biochem Behav. 2007 Mar;86(3):431-40
references.pmid: 17291571
references.citation: Prog Brain Res. 1996;107:437-46
references.pmid: 8782535
references.citation: Brain Res. 1995 Mar 27;675(1-2):89-97
references.pmid: 7796157
references.citation: Neurosci Biobehav Rev. 2010 May;34(6):835-44
references.pmid: 19931556
references.citation: Biol Psychiatry. 2004 Oct 1;56(7):531-4
references.pmid: 15450791
references.citation: Annu Rev Neurosci. 2001;24:897-931
references.pmid: 11520922
references.citation: J Clin Psychiatry. 2007 Oct;68(10):1613-4
references.pmid: 17960979
references.citation: Neurosci Biobehav Rev. 2005;29(8):1207-23
references.pmid: 16095698
references.citation: Eur J Pharmacol. 2004 Feb 6;485(1-3):145-58
references.pmid: 14757135
references.citation: Arch Gen Psychiatry. 2000 Oct;57(10):925-35
references.pmid: 11015810
references.citation: Biol Psychiatry. 2008 Jan 15;63(2):139-45
references.pmid: 17585886
references.citation: Biol Psychiatry. 1999 Aug 1;46(3):442-4
references.pmid: 10435213
references.citation: Physiol Rev. 2007 Jul;87(3):873-904
references.pmid: 17615391
references.citation: Psychopharmacology (Berl). 2005 Jul;180(2):215-23
references.pmid: 15696320
references.citation: Arch Gen Psychiatry. 2010 Apr;67(4):369-79
references.pmid: 20368512
references.citation: Psychopharmacology (Berl). 2002 May;161(3):222-32
references.pmid: 12021825
references.citation: Curr Pharm Des. 2006;12(31):4071-88
references.pmid: 17100612
references.citation: Biol Psychiatry. 1999 Nov 1;46(9):1167-80
references.pmid: 10560023
references.citation: Brain Res Mol Brain Res. 2001 Apr 18;89(1-2):29-40
references.pmid: 11311973
references.citation: Biol Psychiatry. 2004 Dec 1;56(11):898-900
references.pmid: 15576069
references.citation: Annu Rev Neurosci. 2000;23:155-84
references.pmid: 10845062
references.citation: Biol Psychiatry. 2003 Dec 15;54(12):1382-8
references.pmid: 14675802
references.citation: Peptides. 2004 Mar;25(3):319-29
references.pmid: 15134857
references.citation: Am J Psychiatry. 2008 May;165(5):617-20
references.pmid: 18413705
references.citation: Pharmacopsychiatry. 2000 Sep;33(5):189-93
references.pmid: 11071021
references.citation: J Pharmacol Exp Ther. 1988 Dec;247(3):902-10
references.pmid: 2849675
references.citation: Behav Brain Res. 2006 Jun 30;170(2):333-6
references.pmid: 16600394
references.citation: Psychol Rev. 2001 Jul;108(3):483-522
references.pmid: 11488376
references.citation: Endocrinology. 1999 Jan;140(1):79-86
references.pmid: 9886810
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):829-41
references.pmid: 15893820
references.citation: Behav Brain Res. 2003 Dec 17;147(1-2):55-64
references.pmid: 14659570
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1299-306
references.pmid: 19342506
references.citation: Eur J Pharmacol. 1997 Mar 26;323(1):21-6
references.pmid: 9105872
references.citation: World J Biol Psychiatry. 2000 Apr;1(2):105-11
references.pmid: 12607206
references.citation: Neuropsychopharmacology. 2003 Mar;28(3):569-76
references.pmid: 12629539
references.citation: Trends Neurosci. 2007 Aug;30(8):399-406
references.pmid: 17629579
references.citation: Biol Psychiatry. 1998 Dec 15;44(12):1277-85
references.pmid: 9861470
references.citation: Psychoneuroendocrinology. 2008 Sep;33(8):1093-101
references.pmid: 18676086
references.citation: Science. 1981 Sep 18;213(4514):1394-7
references.pmid: 6267699
references.citation: Psychopharmacol Bull. 2004 Winter;38(1):14-20
references.pmid: 15278013
references.citation: Brain Struct Funct. 2008 Sep;213(1-2):29-42
references.pmid: 18528706
references.citation: Biol Psychiatry. 2003 Nov 15;54(10):1041-8
references.pmid: 14625146
references.citation: Nat Neurosci. 2005 Mar;8(3):365-71
references.pmid: 15696163